Global CRISPR Market Report 2018
Wiseguyreports.Com
Adds “CRISPR Market -Market Demand, Growth, Opportunities, Manufacturers,
Analysis of Top Key Players and Forecast to 2025” To Its Research Database.
Description:
Global CRISPR
Market Size Study by Application(Genome Editing, Genetic Engineering, Gene
Library, CRISPR Plasmid, Human Stem cells, Genetically Modified Organism, Cell
Line Engineering), by End-User (Biotechnology Companies, Pharmaceutical
Companies, Academic Institutes, Research & Development Institutes) and
Regional Forecast 2017-2025 USD Billion and Million Units)
Global CRISPR
Market to reach USD 6000 million by 2025.
Global CRISPR
market is valued approximately USD 248 million in 2015. The growth is primarily
driven by the rising demand for drug discovery and a significant rise in
research spending. Further, increasing prevalence of genetic disorders due to
late pregnancies and changing lifestyle patterns have drawn the significant
attention of the researchers towards this emerging technology.
Due to easy
availability of gene editing tools and cost-effectiveness, the technology has
the highest adoption Gene Editing application. Some more applications include
Genetic Engineering, Cell Line Engineering, and others. However, these
applications still have restricted use due to some ethical issues. The total
market revenue has been broadly segmented into application segment, end-user
segment, and geography. Each of the segments is further divided as follows:
Applications:
§ Genome Editing
§ Genetic Engineering
§ Gene Library
§ CRISPR Plasmid
§ Human Stem Cells
§ Genetically Modified Crops (GMO)
§ Cell Line Engineering
§ Genome Editing
§ Genetic Engineering
§ Gene Library
§ CRISPR Plasmid
§ Human Stem Cells
§ Genetically Modified Crops (GMO)
§ Cell Line Engineering
End User:
§ Biotechnology Companies
§ Pharmaceutical Companies
§ Academic Institutes
§ Research & Development Institutes
§ Biotechnology Companies
§ Pharmaceutical Companies
§ Academic Institutes
§ Research & Development Institutes
Request for Sample Report https://www.wiseguyreports.com/sample-request/2742033-global-crispr-market-size-study-by-application-genome-editing-genetic
Regions:
§ North America
o U.S.
o Canada
§ Europe
o UK
o Germany
o France
§ Asia Pacific
o China
o India
o Japan
§ Latin America
o Brazil
o Mexico
§ Rest of the World
§ North America
o U.S.
o Canada
§ Europe
o UK
o Germany
o France
§ Asia Pacific
o China
o India
o Japan
§ Latin America
o Brazil
o Mexico
§ Rest of the World
Among end-user
segment Biotechnology firms and Research & Development Institutes currently
captures more than 60% of total revenue share. High investments from these
end-user segments are the primary driving force for the adoption this emerging
technology. However, during over forecast period, Pharmaceutical firms are
expected to witness highest growth rate. Significant developments in the field
of pharmaceutical biotechnology are expected to generate huge opportunities in
coming years.
The global
market is dominated by North America region followed by Asia Pacific. The
rising prevalence of infertility and genetic disorders in the Asia Pacific
region are the primary driving factors. Agriculture and Animal breeding are the
emerging applications in the Asian countries. North America captures
approximately 38% of the total revenue share in 2015. Europe is also an
emerging region for the development of this technology.
Some of the major players involved in the research and development of CRISPR market are; Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, Inc., CRISPR Therapeutics A, Intellia Therapeutics, Inc., Cellectis, Horizon Discovery PLC, Sigma-Aldrich Corporation, Precision BioSciences, GenScript Corporation, Sangamo Therapeutics, Inc. (SGMO), Lonza Group Limited, Integrated DNA Technologies, New England Biolabs, OriGene Technologies, Inc,.Transposagen Biopharmaceuticals, Inc
Some of the major players involved in the research and development of CRISPR market are; Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, Inc., CRISPR Therapeutics A, Intellia Therapeutics, Inc., Cellectis, Horizon Discovery PLC, Sigma-Aldrich Corporation, Precision BioSciences, GenScript Corporation, Sangamo Therapeutics, Inc. (SGMO), Lonza Group Limited, Integrated DNA Technologies, New England Biolabs, OriGene Technologies, Inc,.Transposagen Biopharmaceuticals, Inc
Complete Detail @
https://www.wiseguyreports.com/reports/2742033-global-crispr-market-size-study-by-application-genome-editing-genetic
Table
of Contents
Chapter
1. Research Methodology
1.1. Research Process
1.1.1. Data Mining
1.1.2. Analysis
1.1.3. Market Estimation
1.1.4. Validation
1.1.5. Publishing
1.2. Research Assumption
1.1. Research Process
1.1.1. Data Mining
1.1.2. Analysis
1.1.3. Market Estimation
1.1.4. Validation
1.1.5. Publishing
1.2. Research Assumption
Chapter
2. Global CRISPR Market Definition & Scope
2.1. Objective of The Study
2.2. Market Definition
2.3. Scope of The Study
2.4. Years Considered for The Study
2.5. Currency Conversion Rates
2.6. Report Limitation
2.1. Objective of The Study
2.2. Market Definition
2.3. Scope of The Study
2.4. Years Considered for The Study
2.5. Currency Conversion Rates
2.6. Report Limitation
Chapter
3. Executive Summary
3.1. Key Trends
3.2. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion/Million)
3.1. Key Trends
3.2. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion/Million)
Chapter
4. Global CRISPR Industry Dynamics
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.3. Porter’s 5 Force Model
4.4. PEST Analysis
4.5. Value Chain Analysis
4.6. Analyst Recommendation & Conclusion
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.3. Porter’s 5 Force Model
4.4. PEST Analysis
4.5. Value Chain Analysis
4.6. Analyst Recommendation & Conclusion
Chapter
5. Global CRISPR Market by Application
5.1. Market Snapshot
5.2. CRISPR Market, Sub Segment Analysis
5.2.1. Genome Editing
5.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.1.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.2. Genetic Engineering
5.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.2.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.3. Gene Library
5.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.3.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.4. CRISPR Plasmid
5.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.4.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.5. Human Stem Cells
5.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.5.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.6. Genetically Modified Crops(GMO)
5.2.6.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.6.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.7. Cell Line Engineering
5.2.7.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.7.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.1. Market Snapshot
5.2. CRISPR Market, Sub Segment Analysis
5.2.1. Genome Editing
5.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.1.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.2. Genetic Engineering
5.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.2.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.3. Gene Library
5.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.3.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.4. CRISPR Plasmid
5.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.4.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.5. Human Stem Cells
5.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.5.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.6. Genetically Modified Crops(GMO)
5.2.6.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.6.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
5.2.7. Cell Line Engineering
5.2.7.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.7.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)
Continued…..
Contact
US:
NORAH
TRENT
Partner
Relations & Marketing Manager
sales@wiseguyreports.com
Ph:
+1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Comments
Post a Comment